# Melatonin for Neuroprotection Following Perinatal Asphyxia

> **NCT02071160** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tanta University** · enrollment: 45 (actual)

## Conditions studied

- Perinatal Asphyxia

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT02071160
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02071160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02071160, "Melatonin for Neuroprotection Following Perinatal Asphyxia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02071160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*